Genky DrugStores Co., Ltd.
9267.T · JPX
9/30/2025 | 6/30/2025 | 6/20/2025 | 3/31/2025 | |
|---|---|---|---|---|
| Revenue | ¥56 | ¥53 | – | ¥49 |
| % Growth | 4.9% | – | – | – |
| Cost of Goods Sold | ¥45 | ¥42 | – | ¥39 |
| Gross Profit | ¥11 | ¥11 | – | ¥10 |
| % Margin | 20.2% | 20.8% | – | 20.3% |
| R&D Expenses | ¥0 | ¥0 | – | ¥0 |
| G&A Expenses | ¥0 | ¥0 | – | ¥0 |
| SG&A Expenses | ¥8 | ¥8 | – | ¥8 |
| Sales & Mktg Exp. | ¥0 | ¥0 | – | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | – | ¥0 |
| Operating Expenses | ¥8 | ¥8 | – | ¥8 |
| Operating Income | ¥3 | ¥3 | – | ¥2 |
| % Margin | 5.2% | 5.3% | – | 4.6% |
| Other Income/Exp. Net | ¥0 | ¥0 | – | ¥0 |
| Pre-Tax Income | ¥3 | ¥3 | – | ¥2 |
| Tax Expense | ¥1 | ¥1 | – | ¥1 |
| Net Income | ¥2 | ¥2 | – | ¥2 |
| % Margin | 3.6% | 4.1% | – | 3.3% |
| EPS | 67.01 | 72.16 | – | 52.8 |
| % Growth | -7.1% | – | – | – |
| EPS Diluted | 66.79 | 72.01 | – | 52.72 |
| Weighted Avg Shares Out | 0 | 0 | – | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | – | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | – | ¥0 |
| Interest Expense | ¥0 | ¥0 | – | ¥0 |
| Depreciation & Amortization | ¥2 | ¥2 | – | ¥2 |
| EBITDA | ¥5 | ¥5 | – | ¥4 |
| % Margin | 8.3% | 8.7% | – | 8.2% |